Trial · NCT03186261
Antibacterial Effect of Nano Silver Fluoride vs Chlorhexidine on Occlusal Carious Molars Treated With Partial Caries Removal Technique
NCT03186261, Phase 3, Completed, Cairo University; results first posted 2021-09-16
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Antibacterial Effect of Nano Silver Fluoride vs Chlorhexidine on Occlusal Carious Molars Treated With Partial Caries Removal Technique. Trials, record NCT03186261. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03186261
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Antibacterial Effect of Nano Silver Fluoride vs Chlorhexidine on Occlusal Carious Molars Treated With Partial Caries Removal Technique
- NCT number
- NCT03186261
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 44 participants, actual
- Lead sponsor
- Cairo University
- Conditions
- Dental Caries
- Interventions
- Nano silver fluoride solution, Cavity Cleanser
- First posted
- 2017-06-14
- Last updated
- 2021-09-16
- Results first posted
- 2021-09-16
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Bacterial Count of Streptococus Mutans | 5 minutes on average between baseline and after application of the solution | Digital Colony Counter, Agar Diffusion test |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Bacterial Count of Streptococus Mutans | 5 minutes on average between baseline and after application of the solution | CFU/ml log10 | MEAN |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Bacterial Count of Streptococus Mutans | Nano Silver Fluoride Solution | Baseline | 2.00 | Standard Deviation 0.33 | CFU/ml log10 |
| Bacterial Count of Streptococus Mutans | Cavity Cleanser | Baseline | 2.04 | Standard Deviation 0.23 | CFU/ml log10 |
| Bacterial Count of Streptococus Mutans | Nano Silver Fluoride Solution | After solution application | 1.12 | Standard Deviation 0.59 | CFU/ml log10 |
| Bacterial Count of Streptococus Mutans | Cavity Cleanser | After solution application | 1.05 | Standard Deviation 0.63 | CFU/ml log10 |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Nano Silver Fluoride Solution | 22 | 22 |
| Overall Study | STARTED | Cavity Cleanser | 22 | 22 |
| Overall Study | COMPLETED | Nano Silver Fluoride Solution | 22 | 22 |
| Overall Study | COMPLETED | Cavity Cleanser | 22 | 22 |
| Overall Study | NOT COMPLETED | Nano Silver Fluoride Solution | 0 | 0 |
| Overall Study | NOT COMPLETED | Cavity Cleanser | 0 | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Nano Silver Fluoride Solution | 0 | 22 |
| Total, all-cause mortality | Cavity Cleanser | 0 | 22 |
| Total, other adverse events | Nano Silver Fluoride Solution | 0 | 22 |
| Total, other adverse events | Cavity Cleanser | 0 | 22 |
| Total, serious adverse events | Nano Silver Fluoride Solution | 0 | 22 |
| Total, serious adverse events | Cavity Cleanser | 0 | 22 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 27041900 | BACKGROUND |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Nano Silver Fluoride Solution vs Cavity Cleanser: deaths from any cause | Trial comparisons |
| Nano Silver Fluoride Solution vs Cavity Cleanser: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03186261
GET https://conductscience.org/api/trials/v1/NCT03186261/registered